Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Yige Fu"'
Autor:
Aishwarya Saraswat, Richa Vartak, Rehab Hegazy, Yige Fu, Trishaal Janardhanam Raghavendra Rao, Blase Billack, Ketan Patel
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 168, Iss , Pp 115754- (2023)
BRAF inhibitors (BRAFi) like vemurafenib (VEM) provide initial regression in mutated melanoma but rapidly develop resistance. Molecular pathways responsible for development of resistance against VEM finally converge towards the activation of oncogeni
Externí odkaz:
https://doaj.org/article/b408c0dac3d44734804bab0180b399b3
Autor:
Yige Fu, Aishwarya Saraswat, Zenghui Wei, Manas Yogendra Agrawal, Vikas V. Dukhande, Sandra E. Reznik, Ketan Patel
Publikováno v:
Pharmaceutics, Vol 13, Iss 7, p 1005 (2021)
A novel treatment strategy by co-targeting c-Myc and tumor stroma was explored in vemurafenib-resistant melanoma. BRD4 proteolysis targeting chimera (ARV-825) and nintedanib co-loaded PEGylated nanoliposomes (ARNIPL) were developed to incorporate a s
Externí odkaz:
https://doaj.org/article/c3edc51cc9e54d0a8d8965a4cd2cc24c
Publikováno v:
Pharmaceutics, Vol 11, Iss 10, p 504 (2019)
The clinical outcomes of malignant melanoma have improved with the introduction of mitogen-activated protein kinase kinase (MEK) inhibitors. However, off-target toxicities of the MEK inhibitor trametinib (TMB) often result in dose interruption and di
Externí odkaz:
https://doaj.org/article/f8c1d6f212b44efa9f9472addebc1694
Autor:
Yuchen Fan, Zhenqi Shi, Shengli Ma, Sayyeda Zeenat Anwer Razvi, Yige Fu, Tao Chen, Jason Gruenhagen, Kelly Zhang
Publikováno v:
Analytical Chemistry. 94:9081-9090
Lipid nanoparticles (LNPs) are the most widely investigated delivery systems for nucleic acid-based therapeutics and vaccines. Loading efficiency of nucleic acids may vary with formulation conditions, and it is considered one of the critical quality
Autor:
Apoorva Sarode, Yuchen Fan, Amy E. Byrnes, Michal Hammel, Greg L. Hura, Yige Fu, Ponien Kou, Chloe Hu, Flora I. Hinz, Jasmine Roberts, Stefan G. Koenig, Karthik Nagapudi, Casper C. Hoogenraad, Tao Chen, Dennis Leung, Chun-Wan Yen
Publikováno v:
Nanoscale advances, vol 4, iss 9
Lipid nanoparticles (LNPs) are gaining traction in the field of nucleic acid delivery following the success of two mRNA vaccines against COVID-19. As one of the constituent lipids on LNP surfaces, PEGylated lipids (PEG-lipids) play an important role
Publikováno v:
Journal of chromatography. A. 1678
Oligonucleotides have emerged as powerful therapeutics for treating diverse diseases. To fully unlock the therapeutic potential of oligonucleotides, there is still a great need to further improve their drug-like properties. Numerous chemical modifica
Publikováno v:
Nanomedicine. 15:1761-1777
Aim: To explore the anticancer activity of a novel BRD4 protein degrader ARV-825 (ARV) and its nanoformulation development (ARV-NP) for treatment of pancreatic cancer. Materials & methods: ARV-NP were prepared using nanoprecipitation method and chara
Autor:
Aashruti Agrawal, Farhan Jalees Ahmad, Faria Ali, null Alka, Mohd. Aqil, M. Arockia Babu, Venkatesh Teja Banala, Sarwar Beg, Aditi Bhat, Valamla Bhavana, Padakanti Sandeep Chary, Vikas Chaudhary, Akash Chaurasiya, Manish K. Chourasia, Harshita Dalvi, Yige Fu, Amruta Gorajiya, Mimansa Goyal, Monica Gulati, Vivek Gupta, Harsha Jain, Dhara Jain, Nitin Jain, Isha Joshi, Kiran Jyoti, Manpreet Kaur, Ayesha Khan, Dharmendra Kumar Khatri, Parveen Kumar, Preeti Kush, Praveen Lakhera, Jitender Madan, Srushti Mahajan, Indrani Maji, Priyanka Maurya, Neelesh Kumar Mehra, Charu Misra, Keerti Mishra, Nidhi Mishra, Dhrubojyoti Mukherjee, Jatinder Kaur Mukker, Jayabalan Nirmal, Raquibun Nisha, Ravi Raj Pal, Vineela Parvathaneni, Ketan Patel, Manali Patki, Rakesh Kumar Paul, Purva Pingle, Ravi Shankar Prasad Singh, Abdul Qadir, Naveen Rajana, Manoj Rawat, Kaisar Raza, Vaskuri G.S. Sainaga Jyothi, Shubhini A. Saraf, Aishwarya Saraswat, Satish Sardana, Deep Shikha Sharma, null Shubhra, Snehal K. Shukla, Neelu Singh, Pankaj Kumar Singh, Priya Singh, Sachin Kumar Singh, Samipta Singh, Shashi Bala Singh, Yuvraj Singh, Rupinder Kaur Sodhi, Veerabomma Haritha Sree, Anitha Sriram, Saurabh Srivastava, Amrendra K. Tiwari, Richa Vartak, Sheetu Wadhwa, Xuechun Wang, Pavan K. Yadav, Sobiya Zafar
Publikováno v:
Multifunctional Nanocarriers ISBN: 9780323850414
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1fa321547f8a8e5c189e4e7fc51def72
https://doi.org/10.1016/b978-0-323-85041-4.01002-7
https://doi.org/10.1016/b978-0-323-85041-4.01002-7
Publikováno v:
Multifunctional Nanocarriers ISBN: 9780323850414
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c2142049c561ff1f69d608b9674cb41
https://doi.org/10.1016/b978-0-323-85041-4.00021-4
https://doi.org/10.1016/b978-0-323-85041-4.00021-4
Publikováno v:
Drug discovery today. 27(4)
Owing to the indispensable role of nanotechnology in cancer therapy, it is imperative to comprehend every aspect limiting its therapeutic potential. Several preclinical reports have demonstrated the enhanced permeability and retention (EPR)-mediated